期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 297, 期 6, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jbc.2021.101391
关键词
-
资金
- Gangstedfonden
- Louis-Hansen Fonden
- TOmrermester JOrgen Holm og Hustru Elisa f. Hansens Mindelegat
- National Institutes of Health [CA199292, HL131474, GM33063]
- National Natural Science Foundation of China [91853131, 81872786]
- Guangdong Provincial Key Laboratory of Drug Nonclinical Evaluation and Research [2018B030323024]
- Alfred Benzon Foundation
- Lundbeck Foundation
Placental malaria infection is mediated by the binding of the malarial VAR2CSA protein to chondroitin sulfate in the placenta, which has similarities to the structure found in cancer cells. The length and accessibility of chondroitin sulfate chains impact the binding of VAR2CSA and malaria infection. Upregulation of proteins involved in chondroitin polymerization in tumors suggests a role in selective tropism of VAR2CSA.
Placental malaria infection is mediated by the binding of the malarial VAR2CSA protein to the placental glycosaminoglycan, chondroitin sulfate. Recombinant subfragments of VAR2CSA (rVAR2) have also been shown to bind specifically and with high affinity to cancer cells and tissues, suggesting the presence of a shared type of oncofetal chondroitin sulfate (ofCS) in the placenta and in tumors. However, the exact structure of ofCS and what determines the selective tropism of VAR2CSA remains poorly understood. In this study, ofCS was purified by affinity chromatography using rVAR2 and subjected to detailed structural analysis. We found high levels of N-acetylgalactosamine 4-O-sulfation (similar to 80-85%) in placenta- and tumor-derived ofCS. This level of 4-O-sulfation was also found in other tissues that do not support parasite sequestration, suggesting that VAR2CSA tropism is not exclusively determined by placenta- and tumor-specific sulfation. Here, we show that both placenta and tumors contain significantly more chondroitin sulfate moieties of higher molecular weight than other tissues. In line with this, CHPF and CHPF2, which encode proteins required for chondroitin polymerization, are significantly upregulated in most cancer types. CRISPR/Cas9 targeting of CHPF and CHPF2 in tumor cells reduced the average molecular weight of cell-surface chondroitin sulfate and resulted in a marked reduction of rVAR2 binding. Finally, utilizing a cell-based glycocalyx model, we showed that rVAR2 binding correlates with the length of the chondroitin sulfate chains in the cellular glycocalyx. These data demonstrate that the total amount and cellular accessibility of chondroitin sulfate chains impact rVAR2 binding and thus malaria infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据